Stay updated on Pembrolizumab with BCG in HR NMIBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.

Latest updates to the Pembrolizumab with BCG in HR NMIBC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a backend/content-management update.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page's revision tag was updated from Revision: v3.6.0 to Revision: v3.6.3 to reflect a newer version.SummaryDifference0.0%

- Check47 days agoChange DetectedBolzano's location entry has been updated to Bolzano, Trentino-Alto Adige, Italy, 39100, replacing the previous Bolzano entry listed under Trentino-Sudtirol. This reflects a regional naming update and provides the same city/address in the study's locations.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a new published version of the study details page.SummaryDifference0.0%

- Check69 days agoChange DetectedThe Locations section updated the Bolzano entry: the region is now Trentino-Sudtirol (instead of Trentino-Alto Adige) and the listing reads Bolzano, Trentino-Sudtirol, Italy, 39100. This reflects a regional naming update and a more precise address for the site.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the page, indicating a new revision of the page metadata.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with BCG in HR NMIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.